Suppr
超能文献

Structural heart disease review of TAVR in low-risk patients: importance of lifetime management.

作者信息

Moumneh Mohamad B, Damluji Abdulla A, Heslop Andras W, Sherwood Matthew W

机构信息

Inova Center of Outcomes Research, Inova Heart and Vascular Institute, Fairfax, VA, United States.

出版信息

Front Cardiovasc Med. 2024 Mar 1;11:1362791. doi: 10.3389/fcvm.2024.1362791. eCollection 2024.

DOI:10.3389/fcvm.2024.1362791

PMID:38495939

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10941982/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80a2/10941982/a42c8f77c653/fcvm-11-1362791-g001.jpg

相似文献

Structural heart disease review of TAVR in low-risk patients: importance of lifetime management.

Front Cardiovasc Med. 2024 Mar 1;11:1362791. doi: 10.3389/fcvm.2024.1362791. eCollection 2024.

Percutaneous Coronary Intervention of Complex Calcific Coronary Lesions Utilizing Orbital Atherectomy Prior to Transcatheter Aortic Valve Replacement.

Cardiovasc Revasc Med. 2022 Apr;37:82-85. doi: 10.1016/j.carrev.2021.06.117. Epub 2021 Jun 22.

Comparison of a Complete Percutaneous Versus Surgical Approach to Aortic Valve Replacement and Revascularization in Patients at Intermediate Surgical Risk: Results From the Randomized SURTAVI Trial.

Circulation. 2019 Oct 15;140(16):1296-1305. doi: 10.1161/CIRCULATIONAHA.118.039564. Epub 2019 Sep 3.

Coronary revascularization during treatment of severe aortic stenosis: A meta-analysis of the complete percutaneous approach (PCI plus TAVR) versus the complete surgical approach (CABG plus SAVR).

J Card Surg. 2020 Aug;35(8):2009-2016. doi: 10.1111/jocs.14814. Epub 2020 Jul 15.

Coronary angiography and percutaneous coronary intervention after transcatheter aortic valve replacement: Feasibility in clinical practice.

Percutaneous Coronary Intervention Pre-TAVR: Current State of the Evidence.

Curr Cardiol Rep. 2022 Aug;24(8):1011-1020. doi: 10.1007/s11886-022-01717-1. Epub 2022 May 27.

Lifetime management of aortic valve disease: Aligning surgical and transcatheter armamentarium to set the tone for the present and the future.

J Card Surg. 2022 Jan;37(1):205-213. doi: 10.1111/jocs.16110. Epub 2021 Oct 25.

Aortic Stenosis and Coronary Artery Disease: Cost of Transcatheter vs Surgical Management.

Ann Thorac Surg. 2022 Sep;114(3):659-666. doi: 10.1016/j.athoracsur.2021.08.028. Epub 2021 Sep 22.

Transcatheter aortic valve replacement- management of patients with significant coronary artery disease undergoing aortic valve interventions: surgical compared to catheter-based approaches in hybrid procedures.

BMC Cardiovasc Disord. 2019 May 14;19(1):108. doi: 10.1186/s12872-019-1087-2.

Procoagulant effect of extracellular vesicles in patients after transcatheter aortic valve replacement or transcatheter aortic valve replacement with percutaneous coronary intervention.

J Thromb Thrombolysis. 2023 Aug;56(2):264-274. doi: 10.1007/s11239-023-02835-5. Epub 2023 Jun 7.

引用本文的文献

Clinical outcomes of transcatheter aortic valve replacement in patients with radiation-induced aortic stenosis: a systematic review and meta-analysis.

Front Cardiovasc Med. 2025 Aug 12;12:1537220. doi: 10.3389/fcvm.2025.1537220. eCollection 2025.

本文引用的文献

The Multidisciplinary Heart Team in Cardiovascular Medicine: Current Role and Future Challenges.

JACC Adv. 2023 Jan 11;2(1):100160. doi: 10.1016/j.jacadv.2022.100160. eCollection 2023 Jan.

Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years.

N Engl J Med. 2023 Nov 23;389(21):1949-1960. doi: 10.1056/NEJMoa2307447. Epub 2023 Oct 24.

Outcomes of Transcatheter Aortic Valve Replacement in Asymptomatic or Minimally Symptomatic Aortic Stenosis.

JACC Cardiovasc Interv. 2023 Nov 13;16(21):2631-2641. doi: 10.1016/j.jcin.2023.07.007. Epub 2023 Sep 20.

Outcomes of Bioprosthetic Valve Fracture in Patients Undergoing Valve-in-Valve TAVR.

JACC Cardiovasc Interv. 2023 Mar 13;16(5):530-539. doi: 10.1016/j.jcin.2022.12.019.

3-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis.

J Am Coll Cardiol. 2023 May 2;81(17):1663-1674. doi: 10.1016/j.jacc.2023.02.017. Epub 2023 Mar 5.

Factors Affecting Rate of Progression of Aortic Stenosis and Its Impact on Outcomes.

Am J Cardiol. 2022 Dec 15;185:53-62. doi: 10.1016/j.amjcard.2022.09.016. Epub 2022 Oct 11.

Asymptomatic Severe Aortic Stenosis: Contemporary Evaluation and Management.

Heart Views. 2022 Jan-Mar;23(1):16-21. doi: 10.4103/heartviews.heartviews_34_22. Epub 2022 May 16.

Cautious Optimism Regarding Early Transcatheter Aortic Valve Replacement.

J Am Heart Assoc. 2022 May 17;11(10):e026010. doi: 10.1161/JAHA.122.026010. Epub 2022 May 10.

Is Asymptomatic Severe Aortic Stenosis Still a Waiting Game?

Circulation. 2022 Mar 22;145(12):874-876. doi: 10.1161/CIRCULATIONAHA.121.058598. Epub 2022 Mar 21.

Practical Approach to Transcatheter Aortic Valve Implantation and Bioprosthetic Valve Fracture in a Failed Bioprosthetic Surgical Valve.

J Interv Cardiol. 2022 Feb 15;2022:9899235. doi: 10.1155/2022/9899235. eCollection 2022.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Suppr超能文献

Structural heart disease review of TAVR in low-risk patients: importance of lifetime management.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译